| Literature DB >> 25619259 |
Masato Sanosaka1, Minoru Fujimoto, Tomoharu Ohkawara, Takahiro Nagatake, Yumi Itoh, Mai Kagawa, Ayako Kumagai, Hiroyuki Fuchino, Jun Kunisawa, Tetsuji Naka, Hiroshi Takemori.
Abstract
Macrophages play important roles in the innate immune system during infection and systemic inflammation. When bacterial lipopolysaccharide (LPS) binds to Toll-like receptor 4 on macrophages, several signalling cascades co-operatively up-regulate gene expression of inflammatory molecules. The present study aimed to examine whether salt-inducible kinase [SIK, a member of the AMP-activated protein kinase (AMPK) family] could contribute to the regulation of immune signal not only in cultured macrophages, but also in vivo. LPS up-regulated SIK3 expression in murine RAW264.7 macrophages and exogenously over-expressed SIK3 negatively regulated the expression of inflammatory molecules [interleukin-6 (IL-6), nitric oxide (NO) and IL-12p40] in RAW264.7 macrophages. Conversely, these inflammatory molecule levels were up-regulated in SIK3-deficient thioglycollate-elicited peritoneal macrophages (TEPM), despite no impairment of the classical signalling cascades. Forced expression of SIK3 in SIK3-deficient TEPM suppressed the levels of the above-mentioned inflammatory molecules. LPS injection (10 mg/kg) led to the death of all SIK3-knockout (KO) mice within 48 hr after treatment, whereas only one mouse died in the SIK1-KO (n = 8), SIK2-KO (n = 9) and wild-type (n = 8 or 9) groups. In addition, SIK3-KO bone marrow transplantation increased LPS sensitivity of the recipient wild-type mice, which was accompanied by an increased level of circulating IL-6. These results suggest that SIK3 is a unique negative regulator that suppresses inflammatory molecule gene expression in LPS-stimulated macrophages.Entities:
Keywords: AMP-activated protein kinase; endotoxin shock; inducible nitric oxide synthase; interleukin-12p40; interleukin-1β; interleukin-6; macrophage; salt-inducible kinases; tumour necrosis factor-α
Mesh:
Substances:
Year: 2015 PMID: 25619259 PMCID: PMC4427391 DOI: 10.1111/imm.12445
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397